Otsuka Holdings Co., Ltd. (OTSKF)

Market Cap	26.17B
Revenue (ttm)	15.98B
Net Income (ttm)	2.34B
Shares Out	n/a
EPS (ttm)	4.34
PE Ratio	11.17
Forward PE	n/a
Dividend	0.80 (1.61%)
Ex-Dividend Date	Jun 27, 2025

Volume	1,500
Average Volume	1,326
Open	49.50
Previous Close	49.85
Day's Range	49.50 - 49.50
52-Week Range	39.48 - 66.15
Beta	0.08
RSI	56.18
Earnings Date	Jul 31, 2025

About Otsuka Holdings

Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. It also provides clinical testing, medical equipment, food products, cosmetics, functional food products, chemical products, soft drinks, beverages, analytical and measurement instruments, nutr...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1921
• Employees: 35,338
• Stock Exchange: OTCMKTS
• Ticker Symbol: OTSKF

Financial Performance

In 2024, Otsuka Holdings's revenue was 2.33 trillion, an increase of 15.42% compared to the previous year's 2.02 trillion. Earnings were 343.12 billion, an increase of 182.13%.

Financial numbers in JPY